|
产品描述
|
Certainly! Here's a structured format for supplementing and improving product information for a biological product like Human IL-17A:
---
Product Name: Human IL-17A
Product Description:
Human IL-17A is a pro-inflammatory cytokine that plays a crucial role in immune response regulation and inflammatory processes. It is primarily produced by T-helper 17 (Th17) cells and is involved in the pathogenesis of various autoimmune and inflammatory diseases. This recombinant IL-17A is expressed in a suitable expression system and purified to high standards, ensuring biological activity and consistency for research applications.
Key Features:
- High Purity: The product is meticulously purified to ensure a high degree of purity, minimizing contaminants and ensuring biological activity.
- Biological Activity: Retains full biological activity, making it suitable for cell-based assays and in vivo studies.
- Consistency: Manufactured under stringent conditions to ensure batch-to-batch consistency.
- Versatility: Can be used in a variety of research applications, including immunological studies and drug development.
Storage:
- Short-term Storage: Store at 2-8°C for up to one month.
- Long-term Storage: For extended storage, keep at -20°C to -80°C. Avoid repeated freeze-thaw cycles to maintain product integrity.
- Stability: Stable for 12 months from the date of receipt when stored properly. Ensure that the product is protected from light and moisture.
What's Included:
- Vial of Human IL-17A: Supplied in a lyophilized form or as a liquid solution, depending on the product format.
- Certificate of Analysis: Provides detailed information on the product's specifications, purity, and activity.
- Product Datasheet: Includes comprehensive information on product use, handling, and experimental protocols.
Applications:
- Immunology Research: Study the role of IL-17A in immune response modulation and inflammatory processes.
- Disease Models: Use in models of autoimmune diseases such as psoriasis, rheumatoid arthritis, and multiple sclerosis.
- Drug Development: Evaluate the efficacy of potential therapeutic agents targeting IL-17A pathways.
- Cell Signaling Studies: Investigate the signaling mechanisms and pathways activated by IL-17A.
---
This structure ensures comprehensive and clear communication of the product's attributes and benefits, aiding researchers in understanding its potential applications and proper handling.
|